Tamoxifen Resistance in American Male Breast Cancer: Molecular Mechanisms and Treatment Strategies
Reading Time: 2 minutes Introduction Breast cancer, though less common in males than in females, presents unique challenges and therapeutic considerations. Among these, the development of resistance to tamoxifen, a widely used selective estrogen receptor modulator (SERM), is a significant concern. This article delves into the molecular mechanisms underlying tamoxifen resistance in American males with breast cancer, offering novel insights that could pave the way for more effective treatment strategies. The Prevalence of Breast Cancer in American Males Breast cancer in males accounts for approximately 1% of all breast cancer cases in the United States. Despite its rarity, the impact on affected individuals is...


